Kumud Kalia
Disclosed holdings of Kumud Kalia as of 2026-10-01: 43K shares of Guardant Health (GH), worth about $6.75M at the last close. From SEC Form 4 filings; not a…
What Kumud Kalia reported holding
As of the latest filing on , Kumud Kalia reported holding 42,773 shares of Guardant Health (GH), worth about $6.75M at the last close of $158 (Oct 19, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Guardant Health GH | 42,773 | 43K direct | $158 | $6.75M | Oct 1, 2026 |
Is this Kumud Kalia’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2022
Kumud Kalia bought shares on the open market in 2023 and 2024, and has not bought since 2024. Sales in each of the last 4 years.
Kumud Kalia reported 3 open-market purchases and 9 sales since 2022; purchases in 2 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 3×3 trades |
| 2024 | 1×1 trade | 1×1 trade |
| 2023 | 2×2 trades | 3×3 trades |
| 2022 | — | 2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Guardant Health GH
Kumud Kalia reported 3 open-market purchases and 9 sales here, 2022 to 2025.
- Market value
- $21.2B
- Last close
- $157.88
- 12 months
- +141.2%
- Against the S&P 500
- +125.8 pts
- Net margin
- -42.4%
- Revenue (last year)
- $982M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Kumud Kalia's trades
Has Kumud Kalia bought shares on the open market?
Kumud Kalia bought shares on the open market in 2023 and 2024, and has not bought since 2024. Sales in each of the last 4 years.
When did Kumud Kalia last buy or sell shares?
In SEC filings since 2022: the latest open-market purchase is from 2024; the latest open-market sale is from 2025.
Which companies has Kumud Kalia traded as an insider?
Guardant Health (GH), from 2022 to 2025: 3 purchases and 9 sales.